Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q3 2014 (← Previous) (Next →)

Filing Date: Nov 13, 2014

Total Value: $1.338B (100.0% shares, 0.0% debt)

Holdings (43)

UTHR UNITED THERAPEUTICS CORP DEL 12.5%
Value $167M Shares 1,298,828 Est. Cost $71.44 Unrealized +44.3%
AUXILIUM PHARMACEUTICALS INC 10.8%
Value $145M Shares 4,854,631 Est. Cost $17.45 Unrealized
CUBIST PHARMACEUTICALS INC 9.1%
Value $122M Shares 1,843,688 Est. Cost $59.40 Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 6.8%
Value $91.24M Shares 1,264,397 Est. Cost $63.78 Unrealized +3.0%
CYBERONICS INC 6.2%
Value $82.94M Shares 1,621,101 Est. Cost $52.15 Unrealized
CLOVIS ONCOLOGY INC 5.8%
Value $78.1M Shares 1,721,757 Est. Cost $45.31 Unrealized
ABIOMED INC 4.5%
Value $60.33M Shares 2,429,524 Est. Cost $21.63 Unrealized
ANACOR PHARMACEUTICALS INC 3.9%
Value $51.8M Shares 2,116,665 Est. Cost $10.16 Unrealized
AMAG PHARMACEUTICALS INC 3.8%
Value $51.52M Shares 1,614,536 Est. Cost $22.29 Unrealized
INSM INSMED INC 3.8%
Value $50.79M Shares 3,892,199 Est. Cost $14.73 Unrealized +2.4%
NPS PHARMACEUTICALS INC 3.3%
Value $44.19M Shares 1,699,562 Est. Cost $27.84 Unrealized
KYTHERA BIOPHARMACEUTICALS I 2.7%
Value $36.11M Shares 1,102,181 Est. Cost $37.70 Unrealized
VNDA VANDA PHARMACEUTICALS INC 2.5%
Value $34.08M Shares 3,283,124 Est. Cost $7.79 Unrealized +68.3%
SEQUENOM INC 2.2%
Value $29.14M Shares 9,810,442 Est. Cost $3.91 Unrealized
STAA STAAR SURGICAL CO 2.1%
Value $27.63M Shares 2,599,553 Est. Cost $8.10 Unrealized +46.8%
WRIGHT MED GROUP INC 1.9%
Value $25.23M Shares 832,729 Est. Cost $30.30 Unrealized
GILD GILEAD SCIENCES INC 1.3%
Value $17.83M Shares 167,500 Est. Cost $55.18 Unrealized +23.3%
MOMENTA PHARMACEUTICALS INC 1.2%
Value $16.5M Shares 1,455,176 Est. Cost $14.44 Unrealized
SHIRE PLC 1.2%
Value $16.5M Shares 63,700 Est. Cost $233.03 Unrealized
ALIMERA SCIENCES INC 1.2%
Value $16.48M Shares 3,040,260 Est. Cost $4.88 Unrealized
CELGENE CORP 1.2%
Value $16.26M Shares 171,600 Est. Cost $87.84 Unrealized
CELLADON CORP 1.1%
Value $15.24M Shares 1,457,200 Est. Cost $11.92 Unrealized
EXAS EXACT SCIENCES CORP 1.1%
Value $15.07M Shares 777,676 Est. Cost $12.83 Unrealized +42.9%
PRTA PROTHENA CORP PLC 1.1%
Value $14.93M Shares 673,818 Est. Cost $22.22 Unrealized -4.6%
MEDIVATION INC 1.0%
Value $12.86M Shares 130,100 Est. Cost $78.28 Unrealized
ARIAD PHARMACEUTICALS INC 0.9%
Value $12.05M Shares 2,231,717 Est. Cost $6.82 Unrealized
FOLD AMICUS THERAPEUTICS INC 0.9%
Value $11.64M Shares 1,956,376 Est. Cost $3.07 Unrealized +70.5%
ALGN ALIGN TECHNOLOGY INC 0.8%
Value $11.01M Shares 213,100 Est. Cost $52.58 Unrealized +3.6%
INTUITIVE SURGICAL INC 0.8%
Value $10.74M Shares 23,250 Est. Cost $422.23 Unrealized
RIGEL PHARMACEUTICALS INC 0.8%
Value $10.05M Shares 5,180,101 Est. Cost $3.43 Unrealized
ACELRX PHARMACEUTICALS INC 0.7%
Value $8.908M Shares 1,622,654 Est. Cost $5.49 Unrealized
QLT INC 0.6%
Value $8.344M Shares 1,846,075 Est. Cost $4.40 Unrealized
OREXIGEN THERAPEUTICS INC 0.6%
Value $8.227M Shares 1,931,324 Est. Cost $6.46 Unrealized
ZELTIQ AESTHETICS INC 0.5%
Value $6.433M Shares 284,249 Est. Cost $22.63 Unrealized
XOMA CORP DEL 0.2%
Value $2.631M Shares 624,900 Est. Cost $4.20 Unrealized
GERN GERON CORP 0.2%
Value $2.323M Shares 1,161,400 Est. Cost $2.85 Unrealized -13.6%
HYPERION THERAPEUTICS INC 0.1%
Value $1.581M Shares 62,700 Est. Cost $22.00 Unrealized
REVANCE THERAPEUTICS INC 0.1%
Value $1.554M Shares 80,369 Est. Cost $31.50 Unrealized
BIOSPECIFICS TECHNOLOGIES CO 0.1%
Value $1.247M Shares 35,336 Est. Cost $32.67 Unrealized
AVEO PHARMACEUTICALS INC 0.1%
Value $1.063M Shares 958,026 Est. Cost $2.50 Unrealized
SOPHIRIS BIO INC 0.1%
Value $858K Shares 292,900 Est. Cost $3.88 Unrealized
CYTK CYTOKINETICS INC 0.0%
Value $435K Shares 123,686 Est. Cost $6.71 Unrealized -37.4%
MALLINCKRODT PUB LTD CO 0.0%
Value $323K Shares 3,588 Est. Cost $90.02 Unrealized